Ultra performance liquid chromatography pda method for determination of tigecycline in human plasma

Therapeutic Drug Monitoring

Volumn 35, Issue 6, 2013, Pages 853-858

  D'Avolio, Antonio ^a   Peila, Emanuela ^b   Simiele, Marco ^a   Pensi, Debora ^a   Baietto, Lorena ^a   Cusato, Jessica ^a   Cinnirella, Giacoma ^b   De Rosa, Francesco ^a   Di Perri, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b AMEDEO DI SAVOIA HOSPITAL   (Italy)

Author keywords

Human plasma; Quantification; Therapeutic drug monitoring; Tigecycline; UPLC

Indexed keywords

QUINOXALINE; TIGECYCLINE;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DETERMINATION; DRUG MONITORING; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG STABILITY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MAXIMUM PLASMA CONCENTRATION; MEASUREMENT ACCURACY; PDA METHOD; PRIORITY JOURNAL; QUALITY CONTROL; SOLUTION AND SOLUBILITY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANTI-BACTERIAL AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; LIMIT OF DETECTION; MINOCYCLINE; QUALITY CONTROL;

EID: 84889239743     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31829403b1     Document Type: Article

References (27)

1. Pankey GA. Tigecycline. J Antimicrob Chemother. 2005;56: 470-480. (Pubitemid 41264122)
2. Khardori N. Antibiotics-past, present, and future. Med Clin North Am. 2006;90:1049-1076. (Pubitemid 44751024)
3. Stein GE, Craig WA. Tigecycline: a critical analysis. Clin Infect Dis. 2006;43: 518-524. (Pubitemid 44157163)
4. Hoffmann M, DeMaio W, Jordan RA, et al. Metabolism, excretion, and pharmacokinetics of [14C] tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects. Drug Metab Dispos. 2007;35:1543-1553. (Pubitemid 47296047)
5. Ji AJ, Saunders JP, Amorusi P, et al. A sensitive human bone assay for quantitation of tigecycline using LC/MS/MS. J Pharm Biomed Anal. 2008;48:866-875.
6. Ji AJ, Saunders JP, Wadgaonkar ND, et al. A novel antibiotic bone assay by liquid chromatography/tandem mass spectrometry for quantitation of tigecycline in rat bone. J Pharm Biomed Anal. 2007;44:970-979. (Pubitemid 47103248)
7. Ji Ji A, Saunders JP, Amorusi P, et al. Determination of tigecycline in human skin using a novel validated LC-MS/MS method. Bioanalysis. 2010;2:81-94.
8. Li C, Sutherland CA, Nightingale CH, et al. Quantitation of tigecycline, a novel glycylcycline [corrected] by liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;811:225-229. (Pubitemid 39446769)
9. Zorpas KM, Valsami GN, Vryonis EV, et al. Robust and sensitive highperformance liquid chromatographic-UV detection technique for the determination of tigecycline in rabbit plasma. J AOAC Int. 2011;94: 847-856.
10. Bradford PA, Petersen PJ, Young M, et al. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method. Antimicrob Agents Chemother. 2005;49:3903-3909. (Pubitemid 41233048)
11. Muralidharan G, Micalizzi M, Speth J, et al. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. Antimicrob Agents Chemother. 2005;49:220-229. (Pubitemid 40065796)
12. Conte JE Jr, Golden JA, Kelly MG, et al. Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline. Int J Antimicrob Agents. 2005;25:523-529. (Pubitemid 40732607)
13. Rodvold KA, Gotfried MH, Cwik M, et al. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose. J Antimicrob Chemother. 2006;58:1221-1229. (Pubitemid 44884142)
14. FDA. Guidance for Industry: Bioanalytical Method Validation. Available at: http://fdagov/cder/guidance/4252fnlpdf. Accessed May 1, 2001.
15. Rubino CM, Bhavnani SM, Forrest A, et al. Pharmacokineticspharmacodynamics of tigecycline in patients with community-acquired pneumonia. Antimicrob Agents Chemother. 2011;56:130-136.
16. Baietto L, D'Avolio A, De Rosa FG, et al. Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma. Anal Bioanal Chem. 2010;396:791-798.
17. Baietto L, D'Avolio A, De Rosa FG, et al. Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV. Ther Drug Monit. 2009;31:104-109.
18. Baietto L, D'Avolio A, Ventimiglia G, et al. Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma. Antimicrob Agents Chemother. 2010;54:3408-3413.
19. D'Avolio A, Baietto L, Siccardi M, et al. An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients. Ther Drug Monit. 2008;30:662-669.
20. D'Avolio A, Sciandra M, Siccardi M, et al. A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;848:374-378. (Pubitemid 46453292)
21. D'Avolio A, Siccardi M, Sciandra M, et al. HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;859: 234-240. (Pubitemid 350046457)
22. De Francia S, D'Avolio A, De Martino F, et al. New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:1721-1726.
23. D'Avolio A, Simiele M, Baietto L, et al. A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients. Ther Drug Monit. 2010;32:86-92.
24. D'Avolio A, Simiele M, De Francia S, et al. HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC). J Pharm Biomed Anal. 2012;59:109-116.
25. D'Avolio A, Simiele M, Siccardi M, et al. HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions. J Pharm Biomed Anal. 2010;52:774-780.
26. D'Avolio A, Simiele M, Siccardi M, et al. A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation. J Pharm Biomed Anal. 2011; 54:779-788.
27. da Silva LM, Nunes Salgado HR. Tigecycline: a review of properties, applications, and analytical methods. Ther Drug Monit. 2010;32:282-288.